Zacks Investment Research Enlivex Therapeutics Ltd. (ENLV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings...\n more…
TipRanks Financial Blog Enlivex (ENLV) has released an update. Enlivex Therapeutics Ltd has announced its Annual General Meeting for shareholders to be held on October 31, 2024, with key a...\n more…
Accesswire ORLANDO, FL / ACCESSWIRE / August 30, 2024 / RedChip Companies will air interviews with GreenPower Motor Company Inc. (Nasdaq:GP) and Enlivex Therapeutics Ltd. (Nasdaq:ENLV) on the RedChip Small...\n more…
Ticker Report Enlivex Therapeutics (NASDAQ:ENLV - Get Free Report) was upgraded by equities research analysts at EF Hutton Acquisition Co. I to a "strong-buy" rating in a research report issued on Tuesday...\n more…